Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Latanoprost - PolyActiva

Next Previous
Drug Profile

Latanoprost - PolyActiva

Alternative Names: Latanoprost free acid (FA) sustained release (SR) Ocular Implant - PolyActiva; Latanoprost ocular implant - PolyActiva; PA-5108; PA-5346

Latest Information Update: 28 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator PolyActiva
  • Class Antiglaucomas; Eye disorder therapies; Prostaglandins; Small molecules
  • Mechanism of Action Prostaglandin F2 alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Ocular hypertension; Open-angle glaucoma

Most Recent Events

  • 28 Jun 2025 No recent reports of development identified for phase-I development in Open-angle-glaucoma in New Zealand (Intraocular, Implant)
  • 27 Jun 2025 Phase-II clinical trials in Ocular hypertension in USA (Intraocular) (NCT06964191)
  • 19 Jun 2025 Updated efficacy data from a preclinical trial in Open-angle glaucoma released by PolyActiva

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top